Cryptome CEO resigns

By Melissa Trudinger
Tuesday, 19 October, 2004

Cryptome Pharmaceuticals (ASX: CRP) has announced that CEO Jeffrey Travis has resigned for personal reasons.

US expatriate Travis, who was appointed in January shortly after the company floated on the ASX, is expected to return to the US. The company plans to appoint an interim CEO in the near future.

'Low-risk' antibiotic linked to rise of dangerous superbug

A new study has challenged the long-held belief that rifaximin — commonly prescribed to...

Robotic hand helps cultivate baby corals for reef restoration

The soft robotic hand could revolutionise the delicate, labour-intensive process of cultivating...

Stem cell experiments conducted in space

Scientists are one step closer to manufacturing stem cells in space — which could speed up...

Content from other channels on our network

Three states announce BESS projects in a week

Emerson offers solution to reduce energy costs and emissions

CSIRO solar venture nets record seed funding

Rockwell Automation and Microsoft expand cloud and AI partnership

Major US defence company sets up in SA

Rising healthcare facility demands pave way for innovation

Designs unveiled for the new Melton Hospital

AIA Australia launches virtual mental health service

Depressive disorders: 70% of Australians not getting adequate treatment

High blood pressure costs Australia $1.2bn a year

Making the national electricity market fit for purpose

Driving progress in clean energy

A first line of defence in wastewater screening

NSW initiative tackles food waste at the source

NSW celebrates recycling triumph